VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DRTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DRTSAlpha Tau Medical Ltd.
$11.22$1.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDRTSQuarterly Financials

Alpha Tau Medical Ltd. (DRTS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Alpha Tau Medical Ltd. (DRTS) quarterly income statement — complete revenue, gross profit & net income history

DRTS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold000000001.07M0512K0979K00231K776K000
COGS % of Revenue--------------------
Gross Profit00000000-1.07M0-512K0-979K00-231K-776K000
Gross Margin %--------------------
Gross Profit Growth %----100%-100%--9.7%--100%-26.16%-------
Operating Expenses12.6M10.73M9.65M9.31M10.27M8.29M9.05M8.42M8.87M8.93M8.17M8.64M7.99M7.36M8.01M8.78M3.94M3.63M3.48M2.73M
OpEx % of Revenue--------------------
Selling, General & Admin3.03M2.42M2.64M2.14M2.74M2.12M2.19M1.98M2.45M2.25M2.21M2.34M2.6M2.53M2.56M3.55M714K602K481K546K
SG&A % of Revenue--------------------
Research & Development9.58M8.31M7.01M7.17M7.53M6.17M6.87M6.45M7.49M6.67M5.96M6.31M5.38M4.83M5.45M5.24M3.23M3.03M3M2.19M
R&D % of Revenue--------------------
Other Operating Expenses00000000-1000K00000000000
Operating Income-12.6M-10.73M-9.65M-9.31M-10.27M-8.29M-9.05M-8.42M-9.94M-8.93M-8.17M-8.64M-7.99M-7.36M-8.01M-8.78M-3.94M-3.63M-3.48M-2.73M
Operating Margin %--------------------
Operating Income Growth %-22.66%-29.43%-6.56%-10.49%-3.33%7.11%-10.85%2.55%-24.52%-21.3%-1.95%1.56%-102.51%-102.48%-130.36%-221.06%-45.34%-33.95%-82.19%-43.27%
EBITDA-11.37M-10.45M-9.38M-9.03M-10M-8.02M-8.77M-8.16M-8.87M-8.68M-7.66M-8.4M-7.01M-7.11M-7.77M-8.55M-3.17M-3.44M-3.29M-2.57M
EBITDA Margin %--------------------
EBITDA Growth %-13.72%-30.33%-6.92%-10.75%-12.74%7.59%-14.6%2.9%-26.59%-22.02%1.44%1.76%-121.22%-106.5%-136.18%-232.56%-17.78%-28.11%-74.02%-36.03%
D&A (Non-Cash Add-back)1.23M275.5K266.5K275.5K275.5K268.5K280K268.5K1.07M244.75K512K244.75K979K244K244K231K776K189K189K164K
EBIT-12.47M-11.2M-9.18M-9.31M-5.67M-8.29M-9.05M-8.42M-9.94M-8.93M-8.67M-8.64M-7.99M-7.36M-8.01M-8.78M-3.94M-3.63M-3.48M-2.73M
Net Interest Income0-2.34M944K716K800K1.19M1.87M444K763K2.03M1.45M478K7.97M4.74M6.02M-16.96M199.38K-1.17M-3.49M-8.96M
Interest Income00944K716K800K1.19M1.87M444K763K0007.99K4.74K00199.38K000
Interest Expense0000000000007.97M4.74M6.02M16.96M01.17M3.49M8.96M
Other Income/Expense431K-964K-401K716K800K1.37M1.69M444K2.59M3.97M-499K478K4.59M4.74M6.02M-16.96M148K-1.17M-3.49M-8.96M
Pretax Income-12.17M-11.69M-10.05M-8.59M-9.47M-6.92M-7.37M-7.98M-7.36M-4.95M-8.67M-8.17M-3.39M-2.61M-1.99M-25.74M-3.79M-4.8M-6.97M-11.7M
Pretax Margin %--------------------
Income Tax-35K-8K65K99K2K03K1K8K-39K26K21K3K9K6K2K-14K-5K15K11K
Effective Tax Rate %0.29%0.07%-0.65%-1.15%-0.02%0%-0.04%-0.01%-0.11%0.79%-0.3%-0.26%-0.09%-0.34%-0.3%-0.01%0.37%0.1%-0.22%-0.09%
Net Income-12.14M-11.69M-10.11M-8.69M-9.48M-6.92M-7.37M-7.98M-7.37M-4.91M-8.69M-8.19M-3.4M-2.62M-2M-25.74M-3.78M-4.8M-6.98M-11.71M
Net Margin %--------------------
Net Income Growth %-28.07%-68.78%-37.25%-8.9%-28.66%-40.96%15.23%2.52%-116.87%-87.27%-334.87%68.2%10.18%45.32%71.37%-119.83%-56.14%-98.1%-245.73%-479.9%
Net Income (Continuing)-12.14M-11.69M-10.11M-8.69M-9.48M-6.92M-7.37M-7.98M-7.37M-4.91M-8.69M-8.19M-3.4M-2.62M-2M-25.74M-3.78M-4.8M-6.98M-11.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.14-0.14-0.13-0.12-0.14-0.10-0.11-0.11-0.11-0.07-0.13-0.12-0.05-0.04-0.03-0.54-0.08-0.07-0.10-0.17
EPS Growth %0%-41.27%-18.18%-9.09%-27.27%-40.17%15.38%8.33%-124.03%-85.56%-345.21%77.78%38.32%46.26%70.8%-217.65%-25.95%-12.18%-109.2%-255.65%
EPS (Basic)-0.14-0.14-0.13-0.12-0.14-0.10-0.11-0.11-0.11-0.07-0.13-0.12-0.05-0.04-0.03-0.54-0.08-0.07-0.10-0.17
Diluted Shares Outstanding85.67M85.26M80.35M70.45M70.09M69.9M69.87M69.71M69.67M69.47M69.32M69.21M69.11M68.8M68.43M47.5M47.5M67.62M67.62M67.62M
Basic Shares Outstanding85.67M83.75M80.35M70.45M70.09M69.9M69.87M69.71M69.67M69.47M69.32M69.21M69.11M68.8M68.43M47.5M47.5M67.62M67.62M67.62M
Dividend Payout Ratio--------------------